ANIKA THERAPEUTICS INC (ANIK) Stock Analyst Ratings
USA - NASDAQ:ANIK - US0352551081 - Common Stock
9.53 USD
-0.14 (-1.45%)
ChartMill assigns a Buy % Consensus number of 85% to ANIK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.81. This target is 65.9% above the current price.
ANIK was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ANIK.
In the previous month the buy percentage consensus was at a similar level.
ANIK was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-22 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-29 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-05-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-14 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-14 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2024-01-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-11-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-08-14 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2023-08-10 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-31 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-04-14 | Stephens & Co. | Reiterate | Equal-Weight |
| 2023-03-07 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2022-11-09 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2022-10-14 | Stephens & Co. | Reiterate | Equal-Weight |
| 2022-03-09 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2021-11-16 | Stephens & Co. | Initiate | Overweight |
| 2021-07-16 | UBS | Initiate | Neutral |
ANIKA THERAPEUTICS INC / ANIK FAQ
Can you provide the average price target for ANIKA THERAPEUTICS INC stock?
8 analysts have analysed ANIK and the average price target is 15.81 USD. This implies a price increase of 65.9% is expected in the next year compared to the current price of 9.53.
How do analysts rate ANIKA THERAPEUTICS INC (ANIK)?
The consensus rating for ANIKA THERAPEUTICS INC (ANIK) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ANIK stock?
The number of analysts covering ANIKA THERAPEUTICS INC (ANIK) is 8.